196 related articles for article (PubMed ID: 18213483)
1. A phenotype-driven ENU mutagenesis screen for the identification of dominant mutations involved in alcohol consumption.
Pawlak CR; Sanchis-Segura C; Soewarto D; Wagner S; Hrabé de Angelis M; Spanagel R
Mamm Genome; 2008 Feb; 19(2):77-84. PubMed ID: 18213483
[TBL] [Abstract][Full Text] [Related]
2. Efficient gene-driven germ-line point mutagenesis of C57BL/6J mice.
Michaud EJ; Culiat CT; Klebig ML; Barker PE; Cain KT; Carpenter DJ; Easter LL; Foster CM; Gardner AW; Guo ZY; Houser KJ; Hughes LA; Kerley MK; Liu Z; Olszewski RE; Pinn I; Shaw GD; Shinpock SG; Wymore AM; Rinchik EM; Johnson DK
BMC Genomics; 2005 Nov; 6():164. PubMed ID: 16300676
[TBL] [Abstract][Full Text] [Related]
3. Analysis of breeding and pathology helps refine management practices of a large-scale N'-ethyl-N'-nitrosourea mouse mutagenesis programme.
Smith AP; Polley S; Wells S; Stewart M; Vizor L; Humphreys J; Warren MV; Dear N; Cheeseman MT
Lab Anim; 2009 Jan; 43(1):1-10. PubMed ID: 18987059
[TBL] [Abstract][Full Text] [Related]
4. Mouse mutagenesis with the chemical supermutagen ENU.
Probst FJ; Justice MJ
Methods Enzymol; 2010; 477():297-312. PubMed ID: 20699147
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel genetic loci for bone size and mechanosensitivity in an ENU mutant exhibiting decreased bone size.
Srivastava AK; Kapur S; Mohan S; Yu H; Kapur S; Wergedal J; Baylink DJ
J Bone Miner Res; 2005 Jun; 20(6):1041-50. PubMed ID: 15883645
[TBL] [Abstract][Full Text] [Related]
6. ENU mutagenesis screening for dominant behavioral mutations based on normal control data obtained in home-cage activity, open-field, and passive avoidance tests.
Wada Y; Furuse T; Yamada I; Masuya H; Kushida T; Shibukawa Y; Nakai Y; Kobayashi K; Kaneda H; Gondo Y; Noda T; Shiroishi T; Wakana S
Exp Anim; 2010; 59(4):495-510. PubMed ID: 20660996
[TBL] [Abstract][Full Text] [Related]
7. Optimizing screening and mating strategies for phenotype-driven recessive N-ethyl-N-nitrosourea screens in mice.
Barbaric I; Dear TN
J Am Assoc Lab Anim Sci; 2007 Nov; 46(6):44-9. PubMed ID: 17994672
[TBL] [Abstract][Full Text] [Related]
8. Using ENU mutagenesis for phenotype-driven analysis of the mouse.
Stottmann RW; Beier DR
Methods Enzymol; 2010; 477():329-48. PubMed ID: 20699149
[TBL] [Abstract][Full Text] [Related]
9. Enu mouse mutagenesis: generation of mouse mutants with aberrant plasma IgE levels.
Alessandrini F; Jakob T; Wolf A; Wolf E; Balling R; Hrabé de Angelis M; Ring J; Behrendt H
Int Arch Allergy Immunol; 2001; 124(1-3):25-8. PubMed ID: 11306917
[TBL] [Abstract][Full Text] [Related]
10. Two kinds of ENU-induced scant hair mice and mapping of the mutant genes.
Wu BJ; Shao YX; Mao HH; Tang D; Liu J; Xue ZF; Li HD
J Dermatol Sci; 2004 Dec; 36(3):149-56. PubMed ID: 15541636
[TBL] [Abstract][Full Text] [Related]
11. A mutant mouse with a highly specific contextual fear-conditioning deficit found in an N-ethyl-N-nitrosourea (ENU) mutagenesis screen.
Reijmers LG; Coats JK; Pletcher MT; Wiltshire T; Tarantino LM; Mayford M
Learn Mem; 2006; 13(2):143-9. PubMed ID: 16585790
[TBL] [Abstract][Full Text] [Related]
12. ENU mutagenesis in the mouse electrophoretic specific-locus test. 2. Mutational studies of mature oocytes.
Lewis SE; Barnett LB; Shelby MD
Mutat Res; 1992 Dec; 296(1-2):129-33. PubMed ID: 1279399
[TBL] [Abstract][Full Text] [Related]
13. Cytopenia induction by 5-fluorouracil identifies thrombopoietic mutants in sensitized ENU mutagenesis screens.
Anderson NM; Berberovic Z; Berndl E; Bailey ML; Flenniken AM; Osborne LR; Adamson SL; Rossant J; Wang C; Minden MD; McNagny KM; Paulson RF; Barber DL; Stanford WL
Exp Hematol; 2012 Jan; 40(1):48-60. PubMed ID: 21924221
[TBL] [Abstract][Full Text] [Related]
14. A genomewide screening of N-ethyl-N-nitrosourea-mutagenized mice for musculoskeletal phenotypes.
Srivastava AK; Mohan S; Wergedal JE; Baylink DJ
Bone; 2003 Aug; 33(2):179-91. PubMed ID: 14499351
[TBL] [Abstract][Full Text] [Related]
15. Improvement of ENU Mutagenesis Efficiency Using Serial Injection and Mismatch Repair Deficiency Mice.
Gallego-Llamas J; Timms AE; Pitstick R; Peters J; Carlson GA; Beier DR
PLoS One; 2016; 11(7):e0159377. PubMed ID: 27441645
[TBL] [Abstract][Full Text] [Related]
16. Studies on
Cho KH; Cho JW; Song CW
Toxicol Res; 2008 Mar; 24(1):59-68. PubMed ID: 32038778
[TBL] [Abstract][Full Text] [Related]
17. Diabetes models by screen for hyperglycemia in phenotype-driven ENU mouse mutagenesis projects.
Aigner B; Rathkolb B; Herbach N; Hrabé de Angelis M; Wanke R; Wolf E
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E232-40. PubMed ID: 18056790
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide ENU mutagenesis in combination with high density SNP analysis and exome sequencing provides rapid identification of novel mouse models of developmental disease.
Caruana G; Farlie PG; Hart AH; Bagheri-Fam S; Wallace MJ; Dobbie MS; Gordon CT; Miller KA; Whittle B; Abud HE; Arkell RM; Cole TJ; Harley VR; Smyth IM; Bertram JF
PLoS One; 2013; 8(3):e55429. PubMed ID: 23469164
[TBL] [Abstract][Full Text] [Related]
19. Identification of 17 hearing impaired mouse strains in the TMGC ENU-mutagenesis screen.
Kermany MH; Parker LL; Guo YK; Miller D; Swanson DJ; Yoo TJ; Goldowitz D; Zuo J
Hear Res; 2006 Oct; 220(1-2):76-86. PubMed ID: 16949226
[TBL] [Abstract][Full Text] [Related]
20. Large-scale albuminuria screen for nephropathy models in chemically induced mouse mutants.
Rathkolb B; Tran TV; Klempt M; Hrabé de Angelis M; Wanke R; Wolf E; Aigner B
Nephron Exp Nephrol; 2005; 100(4):e143-9. PubMed ID: 15849479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
